An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung Cancer
Clinical trial NCT06436885 · UNKNOWN
Trial details
- NCT number
- NCT06436885
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-28
- Primary completion
- 2025-12-31
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.